Evaluation of Postpartum Posttraumatic Stress Disorder at Angers

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to estimate the prevalence of post-traumatic stress disorder (PTSD) at one month in women who have given birth at the University Hospital of Angers over a period of 1 year.

Clinical Trial Description

Childbirth is a natural process expected, prepared and imagined by all future parents.

A traumatic experience of childbirth and its consequences is a major problem that is often underestimated for women's health. Some women may develop Post Traumatic Stress Disorder (PTSD) after delivery. The literature reports a prevalence of PTSD in relation to childbirth of 1.3 to 6%.

Symptoms of post-traumatic stress can be triggered by any event, perceived as threatening to the life or physical integrity of the person or a third party and causing intense fear, helplessness and horror.

It may be thought that childbirth, by its psychological and physiological characteristics, can be described as an extreme experience and its experience depends on multiple factors. Thus, an innocent childbirth for caregivers can be traumatically experienced by the woman.

The symptoms described are symptoms of avoidance (inability to return to the scene of trauma, denial of trauma), symptoms of intrusion (nightmares, reviviscences) and symptoms of neuro-vegetative hyper activation (sleep disorders, anger, emotional indifference ).

The development of PTSD following childbirth is a known phenomenon, but minimized and very little diagnosed by obstetric teams.

Therefore, it seems interesting to assess the prevalence of PTSD during childbirth in order to optimize our management, that is to identify patients at risk of PTSD and offer them adapted psychological follow-up.

This study also aims to describe the kinetics of the development of post-traumatic postpartum symptoms and to study the risk factors for the development of PTSD. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04160273
Study type	Interventional
Source	University Hospital, Angers
Contact	Guillaume LEGENDRE, MDPhD
Phone	33-(0)2-41-35-44-59
Email	guillaume.legendre@chu-angers.fr
Status	Not yet recruiting
Phase	N/A
Start date	November 2019
Completion date	November 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05708482` - Sling and Swing Positions to Pregnant Women	N/A
Completed	`NCT04208867` - Quality Improvement Project for Reproductive Health Services in India, Phase 1	N/A
Completed	`NCT03407209` - Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses	N/A
Completed	`NCT02304042` - Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial	Phase 3
Completed	`NCT03656601` - Tridimensional Pelvic Floor Ultrasound and Quality of Life Scores Questionnaires in Nulliparous or Parous Women
Active, not recruiting	`NCT01100970` - Cortisol Levels in Infants Born by C-section - Electric Unipolar Needle Versus Electric Bipolar Needle	N/A
Completed	`NCT06036277` - Influence of Immersion in Water During Labor on the Request of Epidural Anesthesia by Pregnant Women
Completed	`NCT03364517` - Extra Hospital Delivery Outside Medical Presence.	N/A
Not yet recruiting	`NCT03840889` - Secondary Postpartum Hemorrhage
Completed	`NCT03965026` - Activity Modeling in Birth Room
Terminated	`NCT02649920` - Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop <6) in the Population of Obese Pregnant Women (BMI >= 30 kg/m²)	N/A
Completed	`NCT04897451` - Quality of Life After Cervical Ripening
Completed	`NCT02474745` - Study of the Type of Pushing at Delivery	N/A
Completed	`NCT02827019` - Newborn in Helathy Birthroom: Assessment of Pratical Home and Mother Lived
Completed	`NCT04729192` - Translation and Validation of the Turkish Version of the ObsQoR-10 Questionnaire (ObsQoR-10T)
Recruiting	`NCT04489602` - Translation and Validation of the French Version of the ObsQoR-10 Questionnaire
Completed	`NCT03953573` - Management of Post-delivery Pain and Its Impact on Resumption of Sexuality
Recruiting	`NCT06016712` - The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes	N/A
Completed	`NCT04208191` - Quality Improvement Project for Maternal Health and Family Planning Services in Kenya	N/A
Completed	`NCT02976311` - Comparison of Inflammatory Responses Subsequent to Different Cesarean Section Techniques	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Postpartum Posttraumatic Stress Disorder at Angers University Hospital (ESPT-PP) — ESPT-PP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms